ABSTRACT
Background: Since 1990, the maternal mortality significantly decreased at global scale as well as the North Africa and Middle East. However, estimates for mortality and morbidity by cause and age at national scale in this region are not available. Method(s): This study is part of the Global Burden of Diseases, Injuries, and Risk Factors study (GBD) 2019. Here we report maternal mortality and morbidity by age and cause across 21 countries in the region from 1990 to 2019. Result(s): Between 1990 and 2019, maternal mortality ratio (MMR) dropped from 148.8 (129.6-171.2) to 94.3 (73.4-121.1) per 100 000 live births in North Africa and Middle East. In 1990, MMR ranged from 6.0 (5.3-6.8) in Kuwait to 502.9 (375.2-655.3) per 100 000 live births in Afghanistan. Respective figures for 2019 were 5.1 (4.0-6.4) in Kuwait to 269.9 (195.8-368.6) in Afghanistan. Percentages of deaths under 25 years was 26.0% in 1990 and 23.8% in 2019. Maternal hemorrhage, indirect maternal deaths, and other maternal disorders rank 1st to 3rd in the entire region. Ultimately, there was an evident decrease in MMR along with increase in socio-demographic index from 1990 to 2019 in all countries in the region and an evident convergence across nations. Conclusion(s): MMR has significantly declined in the region since 1990 and only five countries (Afghanistan, Sudan, Yemen, Morocco, and Algeria) out of 21 nations didn't achieve the Sustainable Development Goal (SDG) target of 70 deaths per 100 000 live births in 2019. Despite the convergence in trends, there are still disparities across countries.Copyright © 2022 Academy of Medical Sciences of I.R. Iran. All rights reserved.
ABSTRACT
The COVID-19 pandemic strongly affected organ procurement and transplantation in France, despite the intense efforts of all participants in this domain. In 2020, the identification and procurement of deceased donors fell by 12% and 21% respectively, compared with the mean of the preceding 2 years. Similarly, the number of new registrations on the national waiting list declined by 12% and the number of transplants by 24%. The 3-month cumulative incidence of death or drop out for worsening condition of patients awaiting a liver transplant was significantly greater in 2020 compared to the previous 2 years. Continuous monitoring at the national level of early post-transplant outcomes showed no deterioration for any organ in 2020. At the end of 2020, less than 1% of transplant candidates and less than 1% of graft recipients - of any organ - had died of COVID-19.Copyright © 2021 The Author(s)
ABSTRACT
Medicinal herbs, including the Asteraceae family (AF), have different antimicrobial and therapeutic effects. Therefore, they can be used as health factors in the food and medicinal industries. In this systematic review, the essential information was collected from the relevant databases, e.g., PubMed, Science Direct, and Google Scholar based on medicinal herbs, AF, essential oil, antimicrobial, antioxidant, therapeutic effect, and COVID-19 keywords. AF can be used as safe preservatives and food additives with a specific amount of consumption in the food industry thanks to their good flavor, antioxidant and antimicrobial effect. Due to their therapeutic effects, they can improve the health role of food. AF herbs contain important bioactive compounds, but not all of them can be used as medicine and food supplements since yarrow, chamomile, and artichoke exhibit toxic effects in high dosage, therefore, the consumption of these herbs should be considered to not endanger the health of the consumer. © 2022, Trends Phytochem. All rights reserved.
ABSTRACT
Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a global threat impacting the lives of millions of people worldwide. Automated detection of lung infections from Computed Tomography scans represents an excellent alternative;however, segmenting infected regions from CT slices encounters many challenges. Objective: Developing a diagnosis system based on deep learning techniques to detect and quantify COVID-19 infection and pneumonia screening using CT imaging. Method: Contrast Limited Adaptive Histogram Equalization pre-processing method was used to remove the noise and intensity in homogeneity. Black slices were also removed to crop only the region of interest containing the lungs. A U-net architecture, based on CNN encoder and CNN decoder approaches, is then introduced for a fast and precise image segmentation to obtain the lung and infection segmentation models. For better estimation of skill on unseen data, a fourfold cross-validation as a resampling procedure has been used. A three-layered CNN architecture, with additional fully connected layers followed by a Softmax layer, was used for classification. Lung and infection volumes have been reconstructed to allow volume ratio computing and obtain infection rate. Results: Starting with the 20 CT scan cases, data has been divided into 70% for the training dataset and 30% for the validation dataset. Experimental results demonstrated that the proposed system achieves a dice score of 0.98 and 0.91 for the lung and infection segmentation tasks, respectively, and an accuracy of 0.98 for the classification task. Conclusions: The proposed workflow aimed at obtaining good performances for the different system’s components, and at the same time, dealing with reduced datasets used for training. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
ABSTRACT
The COVID-19 pandemic strongly affected organ procurement and transplantation in France, despite the intense efforts of all participants in this domain. In 2020, the identification and procurement of deceased donors fell by 12% and 21% respectively, compared with the mean of the preceding 2 years. Similarly, the number of new registrations on the national waiting list declined by 12% and the number of transplants by 24%. The 3-month cumulative incidence of death or drop out for worsening condition of patients awaiting a liver transplant was significantly greater in 2020 compared to the previous 2 years. Continuous monitoring at the national level of early post-transplant outcomes showed no deterioration for any organ in 2020. At the end of 2020, less than 1% of transplant candidates and less than 1% of graft recipients — of any organ — had died of COVID-19.